Found: 56
Select item for more details and to access through your institution.
mFOLFOX6 Plus Panitumumab Versus 5-FU/LV Plus Panitumumab After Six Cycles of Frontline mFOLFOX6 Plus Panitumumab: A Randomized Phase II Study of Patients With Unresectable or Advanced/Recurrent, RAS Wild-type Colorectal Carcinoma (SAPPHIRE)-Study Design and Rationale.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A Phase II Study of XELOX and Cetuximab as First-Line Therapy in Patients With KRAS Wild Type Metastatic Colorectal Cancer (FLEET2 Study).
- Published in:
- 2016
- By:
- Publication type:
- journal article
Use of microsatellite analysis in young patients with colorectal cancer to identify those with hereditary nonpolyposis colorectal cancer.
- Published in:
- Journal of Surgical Oncology, 2002, v. 79, n. 3, p. 157, doi. 10.1002/jso.10064
- By:
- Publication type:
- Article
Efficacy of celecoxib as preemptive analgesia for patients undergoing laparoscopic inguinal hernia repair: a randomized trial.
- Published in:
- Surgery Today, 2021, v. 51, n. 7, p. 1118, doi. 10.1007/s00595-020-02199-w
- By:
- Publication type:
- Article
Hepatectomy for rapidly growing solitary liver metastasis from non-small cell lung cancer: a case report.
- Published in:
- Surgical Case Reports, 2019, v. 5, n. 1, p. N.PAG, doi. 10.1186/s40792-019-0633-6
- By:
- Publication type:
- Article
Level of arterial ligation in sigmoid colon and rectal cancer surgery.
- Published in:
- World Journal of Surgical Oncology, 2016, v. 14, p. 1, doi. 10.1186/s12957-016-0819-3
- By:
- Publication type:
- Article
Heterotopic respiratory mucosa in the rectum: A first case report.
- Published in:
- Virchows Archiv: European Journal of Pathology, 2007, v. 451, n. 5, p. 977, doi. 10.1007/s00428-007-0510-8
- By:
- Publication type:
- Article
Phase III randomised trial comparing 6 vs. 12-month of capecitabine as adjuvant chemotherapy for patients with stage III colon cancer: final results of the JFMC37-0801 study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Phase II study of 5-fluorouracil–leucovorin plus bevacizumab for chemotherapy-naïve older or frail patients with metastatic colorectal cancer (OGSG 0802).
- Published in:
- International Journal of Clinical Oncology, 2020, v. 25, n. 7, p. 1291, doi. 10.1007/s10147-020-01656-3
- By:
- Publication type:
- Article
In vivo F-19 chemical shift imaging with FTPA and antibody-coupled FMIQ.
- Published in:
- 1991
- By:
- Publication type:
- journal article
Effect of Preoperative Immunonutrition on Body Composition in Patients Undergoing Abdominal Cancer Surgery.
- Published in:
- Surgery Today, 2007, v. 37, n. 2, p. 118, doi. 10.1007/s00595-006-3332-4
- By:
- Publication type:
- Article
Association between polymorphisms in EGFR and tumor response during cetuximab and oxaliplatin-based combination therapy in metastatic colorectal cancer: Analysis of data from two clinical trials.
- Published in:
- Oncology Letters, 2019, v. 18, n. 5, p. 4555, doi. 10.3892/ol.2019.10787
- By:
- Publication type:
- Article
A multicenter single-arm Phase II clinical trial of second-line FOLFIRI plus panitumumab after first-line treatment with FOLFOX plus panitumumab for initial RAS wild-type colorectal cancer with evaluation of circulating tumor DNA: A protocol study.
- Published in:
- Oncology Letters, 2019, v. 17, n. 2, p. 1980
- By:
- Publication type:
- Article
BRAF V600E mutation is a predictive indicator of upfront chemotherapy for stage IV colorectal cancer.
- Published in:
- Oncology Letters, 2018, v. 15, n. 2, p. 2195, doi. 10.3892/ol.2017.7553
- By:
- Publication type:
- Article
The effects of chemotherapy on primary small bowel cancer: A retrospective multicenter observational study in Japan.
- Published in:
- Molecular & Clinical Oncology, 2013, v. 1, n. 5, p. 820, doi. 10.3892/mco.2013.150
- By:
- Publication type:
- Article
Multicenter open-label randomized phase II study of second-line panitumumab and irinotecan with or without fluoropyrimidines in patients with KRAS wild-type metastatic colorectal cancer (PACIFIC study).
- Published in:
- 2019
- By:
- Publication type:
- journal article
FcγR and EGFR Polymorphisms as Predictive Markers of Cetuximab Efficacy in Metastatic Colorectal Cancer.
- Published in:
- Molecular Diagnosis & Therapy, 2014, v. 18, n. 5, p. 541, doi. 10.1007/s40291-014-0103-6
- By:
- Publication type:
- Article
Differences in UGT1A1, UGT1A7, and UGT1A9 Polymorphisms between Uzbek and Japanese Populations.
- Published in:
- Molecular Diagnosis & Therapy, 2014, v. 18, n. 3, p. 333, doi. 10.1007/s40291-014-0083-6
- By:
- Publication type:
- Article
Comprehensive genomic evaluation of advanced and recurrent breast cancer patients for tailored precision treatments.
- Published in:
- BMC Cancer, 2024, v. 24, n. 1, p. 1, doi. 10.1186/s12885-023-11442-9
- By:
- Publication type:
- Article
Phase II study of an oxaliplatin-based regimen for relapsed colon cancer patients treated with oxaliplatin-based adjuvant chemotherapy (INSPIRE study).
- Published in:
- 2021
- By:
- Publication type:
- journal article
A phase II study of bevacizumab and irinotecan plus alternate-day S-1 as a second-line therapy in patients with metastatic colorectal cancer: the AIRS study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
A phase II trial to evaluate the efficacy of panitumumab combined with fluorouracil-based chemotherapy for metastatic colorectal cancer: the PF trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Randomized phase II study of cetuximab versus irinotecan and cetuximab in patients with chemo-refractory KRAS codon G13D metastatic colorectal cancer (G13D-study).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Pharmacokinetic dose adjustment of 5-FU in modified FOLFOX7 plus bevacizumab for metastatic colorectal cancer in Japanese patients: a-JUST phase II clinical trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Effect of pH adjustment by mixing steroid for venous pain in colorectal cancer patients receiving oxaliplatin through peripheral vein: a multicenter randomized phase II study (APOLLO).
- Published in:
- 2015
- By:
- Publication type:
- journal article
Molecular characteristics of poorly differentiated adenocarcinoma and signet-ring-cell carcinoma of colorectum.
- Published in:
- International Journal of Cancer, 1999, v. 84, n. 1, p. 33, doi. 10.1002/(SICI)1097-0215(19990219)84:1<33::AID-IJC7>3.0.CO;2-Z
- By:
- Publication type:
- Article
Capecitabine and oxaliplatin combined with bevacizumab are feasible for treating selected Japanese patients at least 75 years of age with metastatic colorectal cancer.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Multicenter Phase II study of FOLFOX or biweekly XELOX and Erbitux (cetuximab) as first-line therapy in patients with wild-type KRAS/BRAF metastatic colorectal cancer: The FLEET study.
- Published in:
- 2015
- By:
- Publication type:
- journal article
Phase II clinical study of modified FOLFOX7 (intermittent oxaliplatin administration) plus bevacizumab in patients with unresectable metastatic colorectal cancer-CRAFT study.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 5, p. 1321, doi. 10.1007/s10637-013-9982-3
- By:
- Publication type:
- Article
Phase I results from a two-part Phase I/II study of cediranib in combination with mFOLFOX6 in Japanese patients with metastatic colorectal cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 4, p. 1511, doi. 10.1007/s10637-011-9693-6
- By:
- Publication type:
- Article
A novel system for predicting the toxicity of irinotecan based on statistical pattern recognition with UGT1A genotypes.
- Published in:
- International Journal of Oncology, 2014, v. 45, n. 4, p. 1381, doi. 10.3892/ijo.2014.2556
- By:
- Publication type:
- Article
FOLFIRI Plus Bevacizumab 5 mg/kg Versus 10 mg/kg as Second-line Therapy in Patients with Metastatic Colorectal Cancer Who Have Failed First-line Bevacizumab Plus Oxaliplatin-based Therapy: A Randomized Phase III Study (EAGLE Study).
- Published in:
- Japanese Journal of Clinical Oncology, 2012, v. 42, n. 2, p. 134, doi. 10.1093/jjco/hyr180
- By:
- Publication type:
- Article
Prospective Phase II Study of FOLFIRI for mCRC in Japan, Including the Analysis of UGT1A1*28/*6 Polymorphisms.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 4, p. 477, doi. 10.1093/jjco/hyr001
- By:
- Publication type:
- Article
Does 1 Year Adjuvant Chemotherapy with Oral 5-FUs in Colon Cancer Reduce the Peak of Recurrence in 1 Year and Provide Long-term OS Benefit?
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 2, p. 299, doi. 10.1093/jjco/hyq209
- By:
- Publication type:
- Article
The Importance of Evaluation of DNA Amplificability in KRAS Mutation Testing with Dideoxy Sequencing using Formalin-fixed and Paraffin-embedded Colorectal Cancer Tissues.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 2, p. 165, doi. 10.1093/jjco/hyq173
- By:
- Publication type:
- Article
Multicentre Phase II Study of XELOX with Bevacizumab in Late-stage Elderly Patients with Unresectable Advanced/Recurrent Colorectal Cancer: An ASCA Study.
- Published in:
- Japanese Journal of Clinical Oncology, 2011, v. 41, n. 1, p. 134, doi. 10.1093/jjco/hyq165
- By:
- Publication type:
- Article
Preventive Effect of Goshajinkigan on Peripheral Neurotoxicity of FOLFOX Therapy: A Placebo-controlled Double-blind Randomized Phase II Study (the GONE Study).
- Published in:
- Japanese Journal of Clinical Oncology, 2009, v. 39, n. 12, p. 847, doi. 10.1093/jjco/hyp100
- By:
- Publication type:
- Article
A Phase II Study of the Global Dose and Schedule of Capecitabine in Japanese Patients with Metastatic Colorectal Cancer.
- Published in:
- Japanese Journal of Clinical Oncology, 2006, v. 36, n. 7, p. 410, doi. 10.1093/jjco/hyl058
- By:
- Publication type:
- Article
Phase II study of S-1 plus leucovorin in patients with metastatic colorectal cancer: Regimen of 1 week on, 1 week off.
- Published in:
- Cancer Science, 2017, v. 108, n. 10, p. 2045, doi. 10.1111/cas.13335
- By:
- Publication type:
- Article
UGT1A1*6, 1A7*3, and 1A9*22 genotypes predict severe neutropenia in FOLFIRI-treated metastatic colorectal cancer in two prospective studies in Japan.
- Published in:
- Cancer Science, 2013, v. 104, n. 12, p. 1662, doi. 10.1111/cas.12283
- By:
- Publication type:
- Article
Surgical outcome of laparoscopic hepatic resection for hepatocellular carcinoma: A matched case-control study with propensity score matching.
- Published in:
- Journal of Minimal Access Surgery, 2018, v. 14, n. 4, p. 277, doi. 10.4103/jmas.JMAS_116_17
- By:
- Publication type:
- Article
Appendix Penetrating Into the Sigmoid Colon: Report of a Case.
- Published in:
- 2000
- By:
- Publication type:
- Letter
Biweekly S-1 plus oxaliplatin (SOX) reintroduction in previously treated metastatic colorectal cancer patients (ORION 2 study): a phase II study to evaluate the efficacy and safety.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 7, p. 836, doi. 10.1007/s10147-019-01414-0
- By:
- Publication type:
- Article
Erratum to: Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
- Published in:
- 2017
- By:
- Publication type:
- Erratum
Preplanned safety analysis of the JFMC37-0801 trial: a randomized phase III study of six months versus twelve months of capecitabine as adjuvant chemotherapy for stage III colon cancer.
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 3, p. 494, doi. 10.1007/s10147-016-1083-9
- By:
- Publication type:
- Article
Multicenter randomized phase II clinical trial of oxaliplatin reintroduction as a third- or later-line therapy for metastatic colorectal cancer-biweekly versus standard triweekly XELOX (The ORION Study).
- Published in:
- International Journal of Clinical Oncology, 2016, v. 21, n. 3, p. 566, doi. 10.1007/s10147-015-0911-7
- By:
- Publication type:
- Article
The rare BRAF VK600-601E mutation as a possible indicator of poor prognosis in rectal carcinoma - a report of a case.
- Published in:
- 2015
- By:
- Publication type:
- Case Study
The rare BRAF VK600-601E mutation as a possible indicator of poor prognosis in rectal carcinoma -- a report of a case.
- Published in:
- BMC Medical Genetics, 2015, v. 16, n. 1, p. 1, doi. 10.1186/s12881-015-0144-7
- By:
- Publication type:
- Article
Double-blind, placebo-controlled, randomized phase II study of TJ-14 (Hangeshashinto) for infusional fluorinated-pyrimidine-based colorectal cancer chemotherapy-induced oral mucositis.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 1, p. 97, doi. 10.1007/s00280-015-2767-y
- By:
- Publication type:
- Article
Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double‑blind, placebo‑controlled trial of goshajinkigan to prevent oxaliplatin‑induced neuropathy.
- Published in:
- 2013
- By:
- Publication type:
- journal article